ROS Therapeutics Holding ApS
-
-
Active
- Registration 39507056
- APS
- Established 23 April, 2018
Relations
Past relations
- Ultimate beneficial owners (UBOs)
-
-
Hanne Damgaard Jensen
2019-04-30 – 75% ownership (2022-01-27 – ) 88.24% ownership (2020-05-10 – 2022-01-26 ) 100% ownership (2019-04-30 – 2020-05-09 ) 75% voting rights (2022-01-27 – ) 88.24% voting rights (2020-05-10 – 2022-01-26 ) 100% voting rights (2019-04-30 – 2020-05-09 )
-
- Legal owners
-
-
SPORCON LIFESCIENCE ADVISORS ApS 10% ownership (2020-05-10 – ) 10% voting rights (2020-05-10 – )
-
HDJ & LEJ Invest ApS 66.67% ownership (2018-04-23 – ) 66.67% voting rights (2018-04-23 – )
-
Pebean Pharma ApS 5% ownership (2023-11-13 – ) 5% voting rights (2023-11-13 – )
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-
2200 HOLDING ApS 25% ownership (2018-04-23 – 2019-04-30 ) 25% voting rights (2018-04-23 – 2019-04-30 )
-
Liltorp-Bondebjerg Invest ApS 25% ownership (2018-04-23 – 2019-04-30 ) 25% voting rights (2018-04-23 – 2019-04-30 )
-
Abihansen Holding IVS 25% ownership (2018-04-23 – 2018-12-14 ) 25% voting rights (2018-04-23 – 2018-12-14 )
-
- Directors
-
-
Hanne Damgaard Jensen
2018-04-23 –
-
- Board members
-
-
Hanne Damgaard Jensen
2018-04-23 – 2019-06-24 -
Mads Hartvig Clausen
2018-04-23 – 2019-06-24 -
Jon Bondebjerg
2018-04-23 – 2019-06-24 -
Christian Philip Hansen
2018-04-23 – 2018-10-31
-
- Subsidiaries
-
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-
ROS Therapeutics Holding ApS 25% ownership (2018-12-14 – 2020-05-09 ) 15% ownership (2020-05-10 – 2021-01-18 ) 10% ownership (2021-01-19 – 2022-01-27 ) 25% voting rights (2018-12-14 – 2020-05-09 ) 15% voting rights (2020-05-10 – 2021-01-18 ) 10% voting rights (2021-01-19 – 2022-01-27 )
-